Lybrel-Birth-Control.com

Wyeth Pharmaceuticals News

Amgen And Wyeth Statement On The FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) BlockersSaturday, September 6, 2008 @ 1:12PMAmgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) safety announcement regarding opportunistic fungal infections in patients treated with Tumor Necrosis Factor (TNF) blockers [marketed as Remicade&r

Final Glance: Pharmaceuticals companiesFriday, September 5, 2008 @ 5:25PMBristol-Myers Squibb fell $.01 or percent, to $21.49. Hospira fell $.43 or 1.1 percent, to $39.01.

FACTBOX-Drugs on U.S. FDA list for possible risksFriday, September 5, 2008 @ 1:01PMSept 5 (Reuters) - The U.S. Food and Drug Administration on Friday began issuing a list of drugs undergoing safety probes after the agency received reports of health problems.

Learn about the World CNS Therapeutics MarketThursday, September 4, 2008 @ 5:51PM Reportlinker.com announces that a new market research report related to the Neurology industry is available in its catalogue.

Final Glance: Pharmaceuticals companiesThursday, September 4, 2008 @ 5:09PMBristol-Myers Squibb fell $.04 or .2 percent, to $21.50. Hospira fell $.81 or 2.0 percent, to $39.44.